The application discloses a kind of multi-agent high
blood pressure clinical decision-making
auxiliary system and method based on data driving, belong to medical
artificial intelligence and
clinical pharmacy cross field.Aiming at the low
blood pressure control rate (11.0%) of 2.45 million high
blood pressure patients in China, lack of
precision medicine tool for primary doctors, adverse reactions caused by low blood pressure caused by
drug are easily ignored and other clinical pain points, the application innovatively proposes "real world
drug warning data→risk
signal automatic identification→
clinical decision-making rule conversion→multi-agent collaborative decision-making→clinical feedback
closed loop" complete technical
route.
System core innovation includes: (1)
drug warning
signal three-level hierarchical automatic conversion engine, establish
signal intensity quantization model, automatically generate red / orange / yellow three-level differential early warning rule;(2) patient characteristic driven dynamic threshold adjustment
algorithm, according to age, combined
disease,
organ function and other risk factors, real-time calculation individualized early warning threshold;(3) five-agent decoupled pipeline architecture (A1 information structure→A2 similar case retrieval→A3 safety warning→A4 decision generation→A5
quality control), adopt
rule engine and large
language model dual-engine collaborative mechanism;(4) four-layer anti-illusion
verification system, through hard rule
verification,
guideline compliance
verification, LLM self-evaluation, literature reference authenticity verification to ensure output reliability;(5) clinical feedback driven continuous learning mechanism, construct "decision→application→follow-up→labeling→fine-tuning" data
closed loop.This
system fills the technical gap between drug warning and
clinical decision support system.